Who owns SILVERBACK THERAPEUTICS?
- Ticker: SBTX
- CUSIP Number: 82835w108
Tip: Access positions for across all investors
Analyze quarterly positions in Silverback Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Silverback Therapeutics stock
Who bought or sold SILVERBACK THERAPEUTICS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | ||
|---|---|---|---|---|---|---|
| FMR | 4.8M | $209M | 40% | Mar 2021 | ||
| EcoR1 Capital | 2.5M | $111M | 0% | Mar 2021 | ||
| BlackRock | 1.2M | $53M | 213% | Mar 2021 | ||
| Vanguard Group | 1.1M | $47M | 2071% | Mar 2021 | ||
| Nantahala Capital Management | 992k | $43M | -18% | Mar 2021 | ||
| Ameriprise Financial | 426k | $19M | -1% | Mar 2021 | ||
| Eventide Asset Management | 371k | $16M | 9% | Mar 2021 | ||
| Point72 Asset Management | 288k | $13M | 100% | Mar 2021 | ||
| Daniel D. Thurber | 266k | $12M | 27% | Mar 2021 | ||
| Geode Capital Management | 219k | $9.5M | 1037% | Mar 2021 | ||
| Woodline Partners | 207k | $9.0M | -4% | Mar 2021 | ||
Setup an alertWant to be notified whenever an investor makes a significant change to their holdings of Silverback Therapeutics? |
||||||
| Franklin Resources | 200k | $8.7M | 0% | Mar 2021 | ||
| State Street Corporation | 192k | $8.4M | 100% | Mar 2021 | ||
| Sphera Funds Management | 168k | $7.3M | -4% | Mar 2021 | ||
| Northern Trust | 135k | $5.9M | 100% | Mar 2021 | ||
| Ally Bridge Group | 129k | $5.6M | 0% | Mar 2021 | ||
| Schroder Investment Management Group | 105k | $4.6M | -10% | Mar 2021 | ||
| Soleus Capital Management | 97k | $4.2M | -10% | Mar 2021 | ||
| Commodore Capital | 97k | $4.2M | 0% | Mar 2021 | ||
| VR Adviser | 85k | $3.7M | -43% | Mar 2021 | ||
| Charles Schwab Investment Management | 84k | $3.7M | 100% | Mar 2021 | ||
| Pictet Asset Management | 78k | $3.4M | -37% | Mar 2021 | ||
| Nuveen Asset Management | 50k | $2.2M | 100% | Mar 2021 | ||
| Bank of New York Mellon | 35k | $1.5M | 100% | Mar 2021 | ||
| Victory Capital Management | 31k | $1.3M | -28% | Mar 2021 | ||
| Jpmorgan Chase & Co | 28k | $1.2M | 100% | Mar 2021 | ||
| Bank Julius Baer & Co. Ltd, Zurich | 28k | $1.2M | 100% | Mar 2021 | ||
| Bank of America Corporation | 27k | $1.2M | 100% | Mar 2021 | ||
| Caas Capital Management | 25k | $1.1M | 0% | Mar 2021 | ||
| Board of Trustees of The Leland Stanford Junior University | 22k | $949k | 0% | Mar 2021 | ||
| California State Teachers Retirement System | 19k | $835k | 100% | Mar 2021 | ||
| Janney Montgomery Scott | 16k | $692k | 45% | Mar 2021 | ||
| HighVista Strategies | 14k | $614k | 100% | Mar 2021 | ||
| Rhumbline Advisers | 13k | $575k | 100% | Mar 2021 | ||
| Ohio Pers | 13k | $545k | 4893% | Mar 2021 | ||
| Deutsche Bank Aktiengesellschaft | 12k | $536k | 147% | Mar 2021 | ||
| Etf Managers | 11k | $435k | 100% | Mar 2021 | ||
| New York State Common Retirement Fund | 7.7k | $336k | 100% | Mar 2021 | ||
| American International | 7.4k | $323k | 100% | Mar 2021 | ||
| Manufacturers Life Insurance Company | 7.0k | $306k | 100% | Mar 2021 | ||
| MetLife Investment Advisors | 5.5k | $241k | 100% | Mar 2021 | ||
| Ing Investment Management | 5.4k | $233k | 100% | Mar 2021 | ||
| Ensign Peak Advisors | 5.0k | $218k | 0% | Mar 2021 | ||
| Wells Fargo & Company | 4.4k | $192k | 100% | Mar 2021 | ||
| UBS Group | 3.5k | $154k | 3705% | Mar 2021 | ||
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 3.1k | $135k | 100% | Mar 2021 | ||
| Legal & General Group | 1.3k | $57k | 9962% | Mar 2021 | ||
| Royal Bank of Canada | 1.2k | $51k | 100% | Mar 2021 | ||
| Summit Investment Advisors | 1.0k | $45k | 100% | Mar 2021 | ||
| Citigroup | 841.00 | $37k | -94% | Mar 2021 | ||
| Tower Research Capital | 657.00 | $29k | 100% | Mar 2021 | ||
| Parallel Advisors | 415.00 | $18k | 152% | Mar 2021 | ||
| Bank Of Montreal | 390.00 | $16k | 100% | Mar 2021 | ||
| Us Bancorp | 48.00 | $2.0k | 100% | Mar 2021 | ||
| Candriam Luxembourg S.C.A. | 13.00 | $1.0k | 100% | Mar 2021 | ||
| Metropolitan Life Insurance Company | 4.00 | $176.000000 | 100% | Mar 2021 | ||
Who sold out of Silverback Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2020 | 138k | $6.9M |
| Goldman Sachs Group | Dec 2020 | 88k | $4.1M |
| Monashee Investment Management | Dec 2020 | 60k | $2.8M |
| Ubs Global Asset Management Americas | Dec 2020 | 58k | $2.7M |
| Farallon Capital Management | Dec 2020 | 48k | $2.2M |
| Pura Vida Investments | Dec 2020 | 45k | $2.1M |
| Pinz Capital Management | Dec 2020 | 40k | $1.9M |
| Frazier Management | Dec 2020 | 36k | $1.7M |
| Samsara BioCapital | Dec 2020 | 25k | $1.2M |
| ExodusPoint Capital Management | Dec 2020 | 21k | $968k |
| Qube Research & Technologies | Dec 2020 | 20k | $903k |
| Jane Street | Dec 2020 | 19k | $882k |
| Wellington Management Company | Dec 2020 | 14k | $641k |
| SG Americas Securities | Dec 2020 | 13k | $598k |
| Tibra Equities Europe | Dec 2020 | 13k | $598k |
| Mirabella Financial Services | Dec 2020 | 11k | $525k |
| Maven Securities | Dec 2020 | 8.3k | $386k |
| Norges Bank Investment Management | Dec 2020 | 5.0k | $232k |
| S.A.C. Capital Advisors | Dec 2020 | 4.4k | $205k |
| Morgan Stanley | Dec 2020 | 2.4k | $110k |
| Davidson Kempner Capital Management | Dec 2020 | 1.0k | $46k |